本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Design Therapeutics, Inc.

15.68
+0.45002.95%
盤後15.680.00000.00%19:30 EDT
成交量:60.81萬
成交額:950.60萬
市值:9.79億
市盈率:-13.27
高:15.96
開:15.44
低:15.27
收:15.23
52周最高:17.25
52周最低:4.92
股本:6,244.14萬
流通股本:3,701.27萬
量比:0.98
換手率:1.64%
股息:- -
股息率:- -
每股收益(TTM):-1.1816
每股收益(LYR):-1.2174
淨資產收益率:-34.13%
總資產收益率:-22.53%
市淨率:4.85
市盈率(LYR):-12.88

資料載入中...

2022/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/04

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/20

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/09/02

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/17

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/06/07

重要事件披露

8-K - Current report
2021/05/10

重要事件披露

8-K - Current report
2021/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/09

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/03/30

重要事件披露

8-K - Current report
2021/03/26

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/23

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/23

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/22

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/22

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/03/16

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/05

SEC問詢函

CORRESP [Cover] - Correspondence